Nilsine Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Nilsine Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.1M	Buy	97,225 +2,142	+2%	+$461K	1.67%	9
2026 Q1	$19.4M	Buy	95,083 +89,843	+1,715%	+$18.6M	1.52%	10
2025 Q4	$1.08M	Buy	+5,240	New	+$1.05M	0.09%	201
2024 Q1	–	Sell	-7,283	Closed	-$1.15M	–	340
2023 Q4	$1.15M	Buy	7,283 +191	+3%	+$27.4K	0.18%	145
2023 Q3	$1.04M	Buy	7,092 +119	+2%	+$18.1K	0.16%	159
2023 Q2	$1.07M	Sell	6,973 -55	-0.8%	-$8.58K	0.16%	160
2023 Q1	$1.09M	Buy	+7,028	New	+$1.1M	0.17%	155

Other funds holding FBT

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

HFM

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

AFA

Arlington Financial Advisors Santa Barbara, California $787M AUM 22.93% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HFP

Holistic Financial Partners Indianapolis, Indiana $164M AUM 32.79% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $400M AUM 39.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

OPAM

Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return

Nilsine Partners's FBT Position: Q2 2026 in Review

Nilsine Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.3% in Q2 2026, buying an estimated $461K and bringing the position to 97,225 shares worth $24.1M. The position accounts for 1.67% of the portfolio, ranked #9.

Nilsine Partners first reported a position in FBT in Q1 2023 and has held it in 7 quarters since. 92 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Nilsine Partners held 97,225 shares of First Trust NYSE Arca Biotechnology Index Fund worth $24.1M as of Q2 2026.
Nilsine Partners bought 2,142 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $461K.
First Trust NYSE Arca Biotechnology Index Fund made up 1.67% of Nilsine Partners's portfolio in Q2 2026, its #9 holding.
Nilsine Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and has held it in 7 quarters since.
92 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.